期刊
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 27, 期 3, 页码 490-495出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2016.12.035
关键词
Carbonic anhydrase; gamma-Class; Inhibitor; Sulfonamide; Sulfamate; Acetazolamide; Drug resistance; Burkholderia pseudomallei
资金
- Distinguished Scientists Fellowship Program (DSFP) from King Saud University, Saudi Arabia
A new gamma-carbonic anhydrase (CA, EC 4.1.1.1) was cloned and characterized kinetically in the genome of the bacterial pathogen Burkholderia pseudomallei, the etiological agent of melioidosis, an endemic disease of tropical and sub-tropical regions of the world. The catalytic activity of this new enzyme, BpsCA gamma, is significant with a k(cat) of 5.3 x 10(5) s(-1) and k(cat)/K-m, of 2.5 x 10(7) M-1 x s(-1) for the physiologic CO2 hydration reaction. The inhibition constant value for this enzyme for 39 sulfonamide inhibitors was obtained. Acetazolamide, benzolamide and metanilamide were the most effective (K(1)s of 149-653 nM) inhibitors of BpsCA gamma activity, whereas other sulfonamides/sulfamates such as ethoxzolamide, topiramate, sulpiride, indisulam, sulthiame and saccharin were active in the micromolar range (K(1)s of 1.27-9.56 mu M). As Burkholderia pseudomallei is resistant to many classical antibiotics, identifying compounds that interfere with crucial enzymes in the B. pseudomallei life cycle may lead to antibiotics with novel mechanisms of action. (C) 2016 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据